Zomedica Pharmaceuticals Corp. Announces Year End 2017 Financial Results
Zomedica Corp. Common Shares (ZOM)
US:NYSE Investor Relations:
investors.zomedica.com
Company Research
Source: GlobeNewswire
ANN ARBOR, Mich., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today reported consolidated financial results for the year ended December 31, 2017. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under accounting principles generally accepted in the United States of America (“U.S. GAAP”). “In less than three years since launching Zomedica, we’ve achieved a number of important milestones in our company’s development, including our initial launch on the TSX Venture Exchange and our November 2017 listing on the NYSE American,” said Gerald Solensky, Jr., Chairman and CEO of Zomedica. “These achievements are a tribute to the hard work and dedication of our people. I am excited about our future and our efforts to fulfill unmet needs of veterinarians as they work to protect the health of our companion animals.” Corporate Highli
Show less
Read more
Impact Snapshot
Event Time:
ZOM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZOM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZOM alerts
High impacting Zomedica Corp. Common Shares news events
Weekly update
A roundup of the hottest topics
ZOM
News
- Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity [Yahoo! Finance]Yahoo! Finance
- Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in LiquidityAccesswire
- Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024 [Yahoo! Finance]Yahoo! Finance
- Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024Accesswire
- Zomedica Expands International Reach with CE Certification for VetGuardian(R) System [Yahoo! Finance]Yahoo! Finance
ZOM
Earnings
- 8/10/23 - Miss
ZOM
Sec Filings
- 5/9/24 - Form 8-K
- 5/9/24 - Form 10-Q
- 4/29/24 - Form ARS
- ZOM's page on the SEC website